Lnc‐ing Pluripotency Maintenance and Early Differentiation in Human Pluripotent Stem Cells
Pei-Jung Lu,Mao Li,Donghui Zhang,Wei Jiang
DOI: https://doi.org/10.1096/fj.202002278r
2021-01-01
Abstract:The FASEB JournalVolume 35, Issue 4 e21438 REVIEWSFree Access Lnc-ing pluripotency maintenance and early differentiation in human pluripotent stem cells Pei Lu, Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, China Pei Lu and Mao Li authors contributed equally.Search for more papers by this authorMao Li, Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, China Pei Lu and Mao Li authors contributed equally.Search for more papers by this authorDonghui Zhang, Corresponding Author dongh.zhang@hubu.edu.cn State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Science, Hubei University, Wuhan, China Correspondence Donghui Zhang, State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Science, Hubei University, 368 Youyi Road, Wuhan, Hubei Province 430062, China. Email: dongh.zhang@hubu.edu.cn Wei Jiang, Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, 116 East-Lake Road, Wuhan, Hubei Province 430071, China. Email: jiangw.mri@whu.edu.cn, jiangw.pku@gmail.comSearch for more papers by this authorWei Jiang, Corresponding Author jiangw.mri@whu.edu.cn jiangw.pku@gmail.com orcid.org/0000-0002-6463-7356 Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, China Human Genetics Resource Preservation Center of Wuhan University, Wuhan, China Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, China Correspondence Donghui Zhang, State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Science, Hubei University, 368 Youyi Road, Wuhan, Hubei Province 430062, China. Email: dongh.zhang@hubu.edu.cn Wei Jiang, Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, 116 East-Lake Road, Wuhan, Hubei Province 430071, China. Email: jiangw.mri@whu.edu.cn, jiangw.pku@gmail.comSearch for more papers by this author Pei Lu, Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, China Pei Lu and Mao Li authors contributed equally.Search for more papers by this authorMao Li, Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, China Pei Lu and Mao Li authors contributed equally.Search for more papers by this authorDonghui Zhang, Corresponding Author dongh.zhang@hubu.edu.cn State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Science, Hubei University, Wuhan, China Correspondence Donghui Zhang, State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Science, Hubei University, 368 Youyi Road, Wuhan, Hubei Province 430062, China. Email: dongh.zhang@hubu.edu.cn Wei Jiang, Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, 116 East-Lake Road, Wuhan, Hubei Province 430071, China. Email: jiangw.mri@whu.edu.cn, jiangw.pku@gmail.comSearch for more papers by this authorWei Jiang, Corresponding Author jiangw.mri@whu.edu.cn jiangw.pku@gmail.com orcid.org/0000-0002-6463-7356 Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, China Human Genetics Resource Preservation Center of Wuhan University, Wuhan, China Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, China Correspondence Donghui Zhang, State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Science, Hubei University, 368 Youyi Road, Wuhan, Hubei Province 430062, China. Email: dongh.zhang@hubu.edu.cn Wei Jiang, Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, 116 East-Lake Road, Wuhan, Hubei Province 430071, China. Email: jiangw.mri@whu.edu.cn, jiangw.pku@gmail.comSearch for more papers by this author First published: 22 March 2021 https://doi.org/10.1096/fj.202002278RCitations: 1 AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat Abstract Pluripotency maintenance and lineage differentiation are two major characteristics of human embryonic and induced pluripotent stem cells. The determination of self-renewal or differentiation is under the exquisite control of the gene regulatory network, which is composed of transcription factors, signaling pathways, metabolic factors, chromatin or histone modifiers, miRNAs, and lncRNAs. Growing evidence has shown that long noncoding RNAs (lncRNAs) play important roles in epigenetic, transcriptional, and posttranscriptional gene regulation during the cell fate determination of pluripotent stem cells. Here, we summarize recent reports of lncRNA functions in pluripotency maintenance/exit and the early germ layer specification of human pluripotent stem cells. We also illustrate four major lncRNA functional mechanisms according to different types of cofactors: chromatin or histone modifiers, transcription factors, canonical and noncanonical RNA-binding proteins, and miRNAs. Further understanding of lncRNA-based regulation will provide more insights into the drivers manipulating cell fate and promote the therapeutic and research potential of human embryonic and induced pluripotent stem cells. Abbreviations CRISPRi CRISPR interference CRISPRa CRISPR activation ESC embryonic stem cell iPSC induced pluripotent stem cell lncRNA long noncoding RNA PSC pluripotent stem cell 1 INTRODUCTION Human embryonic stem cells (ESCs) are derived from the inner cell mass of human blastocysts and with the potential of self-renewal and multidirectional differentiation. In addition, induced pluripotent stem cells (iPSCs) are generated by somatic cell reprogramming with specific transcription factors. Pluripotent stem cells (PSCs), including ESCs and iPSCs, can differentiate into the three germ layers (ie, ectoderm, mesoderm, and endoderm) under the induction of different cytokines or chemicals, which makes them ideal resources for investigating early embryonic development, remodeling human disease, and providing functional cells for use in regenerative medicine. However, the cell fate determination of PSCs is a very complicated regulatory process involving endogenous transcription factors, key signaling pathways, noncoding RNAs, and epigenetic regulators.1 Long noncoding RNAs (lncRNAs), longer than 200 nucleotides and lacking protein-coding potential, have been identified as functional regulatory nodes in multiple biological contexts. LncRNAs can be divided into sense, antisense, intronic, bidirectional, and intergenic transcripts according to their genomic positions relative to protein-coding genes. Although the structure of lncRNAs is similar to mRNAs, lncRNAs are more species- and cell-type-specific, and with lower sequence conservation than mRNAs.2 Importantly, lncRNAs can regulate gene expression in multiple ways, such as chromatin remodeling, transcriptional regulation, and posttranscriptional processing. Numerous studies have shown that lncRNAs interact with DNA, RNA, or protein to regulate gene expression and participate in diverse biological processes. Here, we focus on the link between lncRNAs and human PSC fate determination and summarize and discuss recent studies about the function and mechanism of lncRNAs in pluripotency maintenance and early differentiation. 1.1 Biological function of lncRNAs in PSC pluripotency Transcriptome analysis has identified hundreds of lncRNAs highly expressed in human PSCs. LncRNAs can interact with pluripotency-associated transcription factors or chromatin modifiers to regulate cell identity. Functional studies also show that lncRNAs play indispensable roles in maintaining the PSC pluripotent state. LncRNAs that are highly expressed in pluripotent cells often harbor pluripotent transcription factor-binding sites in their genomic regulatory regions, which suggests that lncRNAs participate in an autofeedback loop with transcription factors and eventually contribute to pluripotency. Ng and colleagues conducted lncRNA microarray analysis in human ESCs and human neural progenitor cells and identified 36 ESC-specific lncRNAs. Among these candidates, three lncRNAs (lncRNA_ES1, lncRNA_ES2, and lncRNA_ES3) are exclusively expressed in undifferentiated ESCs and iPSCs and are regulated by pluripotent transcription factors such as SOX2, OCT4, and NANOG. Knocking down lncRNA_ES1, lncRNA_ES2, or lncRNA_ES3 induced by siRNAs led to decreased pluripotency-related gene expression and elevated germ layer-related gene expression.3 Similarly, a microarray analysis of human ESCs, fibroblasts, and their derived iPSCs showed that 133 lncRNAs were induced in pluripotent stem cells, while 104 lncRNAs were repressed. Additional studies showed that lincRNA-RoR modulates iPSC reprogramming by binding to OCT4, SOX2, and NANOG.4 The lncRNA GAS5, a known tumor suppressor, is highly expressed and directly regulated by OCT4 and SOX2 in human ESCs. GAS5 knockdown leads to cell differentiation with a reduced G2/M phase, but its overexpression promotes ESC self-renewal.5 The transcriptional regulatory factors of lncRNAs can be analyzed with ChIP-seq data, and the results will be of great utility in the study of transcription factor-lncRNA interactions and the biological roles of lncRNAs.6 For example, by integrating RNA-seq and p53-ChIP-seq data (ie, determining genomic binding sites of the p53 protein) in differentiated human ESCs, Jain and colleagues identified 40 p53-regulated lncRNAs and demonstrated the functional mechanism of LncPRESS1. ESCs with depleted LncPRESS1 due to transfection with shRNA showed decreased OCT4 and NANOG expression and elevated lineage-specific marker expression, such as PAX6, HOXA1, and FOXA2.7 Moreover, Guo and colleagues explored sequence or positionally conserved lncRNAs by comparing lncRNA subcellular localization patterns in human ESCs and mouse ESCs. A total of 122 and 229 conserved lncRNAs were identified in human and mouse ESCs, respectively. They reported a sequence and positionally conserved lncRNA FAST function in human ESCs and iPSCs. hFAST knockdown resulted in the reduced expression of OCT4 and NONOG and robust spontaneous differentiation, while the ectopic expression of hFAST rescued the phenotype disrupted by hFAST knockdown. Therefore, hFAST is required for human PSC pluripotency maintenance.8 Taken together, these results indicate that lncRNAs coordinate with the classical pluripotency gene regulation network via hierarchical regulation cascades to promote pluripotency maintenance. There are different states of cultured PSC types, such as primed PSCs, naïve PSCs, formative PSCs and extended pluripotent stem cells or expanded potential stem cells, together composing a hierarchical pluripotency system. These different pluripotent states correspond to different in vivo developmental statuses and exhibit distinct transcriptome and gene regulation networks.9 Recent studies have shown that lncRNAs actively participate in the human naïve pluripotency transition from the conventional primed state. For instance, lincU was characterized as a naïve-state-associated lncRNA in mouse and human ESCs. The overexpression of lincU in primed ESCs promoted the transition into a naïve state, while loss-of-function of lincU in naïve ESCs resulted in a primed-like state and facilitated naïve-to-primed conversion.10 Additionally, a primate-specific endogenous retrovirus-derived noncoding transcript named HERVH was reported to be a hallmark of naïve-like ESCs. Pluripotent transcription factors such as OCT4, NANOG, KLF4, and LBP9 together drive HERVH transcription, which accounts for the high and specific expression of HERVH in human ESCs and iPSCs. In addition, HERVH triggers ESC-specific alternative and chimeric transcripts and lncRNAs to regulate pluripotency. Disruption of LBP9, HERVH, and HERVH-derived transcripts results in impaired self-renewal of human ESCs.11 Moreover, a study screening for candidate pluripotency-associated lncRNAs in 55 human ESC RNA-seq samples identified a lncRNA named CCDC144NL-AS1, a repressor of naïve pluripotency. CCDC144NL-AS1-deficient ESCs showed naïve-like pluripotency with greater capacity to differentiate into the three germ layers.12 In addition to regulating pluripotency gene expression, lncRNAs have important roles in X chromosome inactivation in different pluripotent states,13 such as the XIST14 and XACT lncRNAs.15 These studies show that lncRNAs not only can serve as hallmarks of naïve pluripotency, but can also play essential regulatory roles in the core pluripotent gene circuitry (Figure 1 and Table 1). FIGURE 1Open in figure viewer LncRNA participates in pluripotency maintenance and early differentiation in human PSC. LncRNAs that regulate human PSC self-renewal, pluripotency transition (primed-naive), and early germ layer differentiation (ectoderm, mesoderm, and endoderm) are depicted. Two lncRNAs functioning during the transition from totipotent two-cell to inner cell mass (ICM) in mouse are also illustrated TABLE 1. Roles of regulatory lncRNAs LncRNA Species and cell type Expression Function Mechanism References lncRNA_ES1, lncRNA_ES2, lncRNA_ES3 hESC, hiPSC Highly expressed in hESC but not in NPC Maintains hESC pluripotency Physically interacts with SUZ12 and SOX2 to maintain hESC pluripotency 3 Linc-RoR hESC Highly expressed in hESC but not in embryoid body or differentiated cell Promotes hESC self-renewal and pluripotency Sponges miR-145 to prevent OCT4, SOX2, and NANOG from miRNA-mediated degradation 4 GAS5 hESC Highly expressed in hESC but not in serum-induced differentiated hESC Promotes hESC self-renewal Promotes their degradation of miR-2467/-3200/LET7e, and thus, protecting miRNA target NODAL 5 LncPRESS1 hESC Highly expressed in hESC but not in differentiated cell treated with retinoic acid Maintains hESC pluripotency Sequesters SIRT6 from chromatin and enables enrichment of H3K56/K9ac at active pluripotency gene promoters 7 FAST hESC, hiPSC Highly expressed in hESC and decreased in ectoderm, trophoblast, and mesoderm Maintains hESC pluripotency Binds to E3 ubiquitin ligase β-TrCP and impedes the interaction between β-TrCP and phosphorylated β-catenin, thus, promoting WNT activity 8 LincU mESC, hESC Highly expressed in naïve ESC but not in primed ESC Maintains naive pluripotency of ESC Restricts MAPK/ERK activity by binding and stabilizing ERK-specific phosphatase DUSP9 10 HERVH hESC, hiPSC Highly expressed in hESC but not in embryoid body Maintains hESC pluripotency and marks the naïve-like state in hPSC Regulates hESC-specific alternative and chimaeric transcripts together with LBP9 11 CCDC144NL-AS1 hESC, hiPSC Highly expressed in hPSC but not in somatic tissue Regulates naïve-like pluripotency conversion Target unclear 12 XIST hESC Highly expressed in primed hESC Regulates the transition from primed pluripotency to naïve pluripotency Inactivates X chromosomes in hESC 14 XACT hESC Highly expressed in naïve hESC but not in primed hESC Regulates the transition from primed pluripotency to naïve pluripotency Influences XIST accumulation in cis to regulate X chromosome activity 15 LincGET Mouse embryo Transiently and asymmetrically expressed in the nucleus of two- to four-cell mouse embryos Regulates ICM fate Binds to CARM1 and promotes its nuclear localization which can increase ICM-specific gene expression through H3R26me 16 LINE1 mESC Highly expressed during ICM development Promotes two-cell exit and ICM development Recruits Nucleolin/Kap1 to repress Dux and activate rRNA synthesis 17 tsRMST hESC Highly expressed in hESC but not in embryoid body Impedes hESC differentiation Represses lineage-specific transcription factors through the PRC2 complex and NANOG; represses WNT5A to promote EMT 21,22 TUNA mESC Highly expressed in mESC and specifically expressed in the central nervous system Regulates pluripotency and neural differentiation of ESCs Interacts with and recruits PTBP1, hnRNP-K, and Nucleolin to NANOG, SOX2, and FGF4 promoters to activate transcription 23 yylncT hESC, mESC Highly expressed in mesoderm but not in ESC Regulates ESC differentiation and promotes mesodermal commitment Binds DNMT3B and inhibits its activity at the T locus 24 BANCR hESC, hiPSC Highly expressed in fetal cardiomyocytes but not in PSC Promotes the cardiac differentiation and maturation Positively regulated by cardiogenic TBX5 and TEAD/YAP signaling 25 HBL1 hESC Highly expressed in hESC but not in cardiomyocyte Represses cardiomyocyte development Interacts with miR-1 26 DEANR1 hESC Highly expressed in endoderm but not in hESC Promotes hESC endoderm differentiation Facilitates SMAD2/3 recruitment to FOXA2 promoter 27 DIGIT hESC, mESC Highly expressed in endoderm but not in hESC Regulates definitive endoderm differentiation Positively regulates neighboring GSC transcription; interacts with BRD3 and promotes BRD3 recruitment at H3K18ac regions to enhance endoderm gene expression 28, 29 GATA6-AS1 hESC Highly expressed in endoderm but not in hESC Promotes hESC endoderm differentiation Interacts with SMAD2/3 and activates the transcription of GATA6 30 LINC00458 hESC Highly expressed in endoderm but not in hESC Promotes hESC endoderm differentiation Mediates SMAD2/3 binding to endoderm genes 31 Oct4P4 mESC Upregulated during embryoid body formation Diminishes mESC self-renewal Recruits SUV39H1 and HP1a to Oct4 gene promoter to repress 32 RP-11380D23.2 hiPSC Highly expressed in lung morphogenesis but not in hiPSC Regulates distal-proximal patterning in lung Regulates nearby gene PITX2 depending on PARP1 33 HPAT2, HPAT3, HPAT5 human embryos Expressed specifically in ICM Promotes pluripotency acquisition and ICM formation HPAT5 interacts with Let7-miRNA family and negatively regulates let-7 activity 34 FLJ11812 hESC Highly expressed in hESC but not in embryoid body Promotes hESC stemness Competes with miR-4459 thus protecting miR-4459 target genes CDC20B and ATG13 35 Cyrano zebrafish embryo, mESC, hESC, hiPSC Expressed throughout the developing nervous system in zebrafish and mouse embryo; highly expressed in hPSCs but lower in somatic cell lines Regulates neuronal activity in zebrafish and mice; controversial results in ESC maintenance Promotes miR-7 degradation and protects miR-7 target Cdr1as to regulate neuronal activity in mice; interacts with miR-7 and protects miR-7 targets Nanog and Itga9; interacts with STAT3 protein and inhibits STAT3 targets 36, 37 Haunt mESC Highly expressed in mESC but not in differentiated cell triggered by withdrawal of LIF Regulates ESC differentiation haunt DNA acts as an enhancer to promote HOXA expression while haunt RNA blocks enhancer-promoter contacts and inhibits H3K27me3 demethylation to repress HOXA expression 41 The zygotic period from the single blastomere to the eight-cell stage is considered totipotent in mice and humans, and whether lncRNAs play important roles in this context is of great interest. In two-cell mouse embryos, asymmetrically expressed LincGET was reported to regulate cell fate determination by sequestering histone arginine methyltransferase CARM1 in the nucleus to activate inner cell mass-specific gene expression. Injecting LincGET RNA in one of two-cell embryos drove the transition into the inner cell mass.16 In addition, transcripts from the transposable element LINE1 were reported to function in mouse ESCs and preimplantation embryos. The LINE1 RNA interacts with Nucleolin and KAP1 to facilitate the repression of the two-cell master regulator Dux and the activation of rDNA transcription. During the late two-cell stage to the four-cell stage, knockdown of LINE1 results in the reactivation of two-cell-specific genes and delayed zygotic genome activation, indicating that LINE1 promotes two-cell exit and inner cell mass development.17 Despite these effects were achieved in a mouse model, whether and/or how lncRNAs participate in the regulation of the human early totipotent state remain unknown. However, recent achievements in culturing expanded totipotent-like human PSCs which extend their potential in vitro18, 19 may lead to the development of an advanced system useful for dissecting the functional roles of lncRNAs in totipotency and pluripotency transitions. Indeed, Ma and colleagues recently performed RNA-seq of human primed, naïve, and extended pluripotent stem cells, and their analysis revealed a lncRNA-miRNA-mRNA competing endogenous RNA network,20 offering valuable clues for further experimental validation. 1.2 Biological function of lncRNAs in the early differentiation of human PSCs PSCs can maintain a pluripotent state or undergo spontaneous or directed differentiation under different circumstances. We have explained that some lncRNAs are essential for ESC identity and pluripotency maintenance, while other lncRNAs take part in the regulation of ESC pluripotency exit and cell differentiation, including early embryonic germ layer differentiation (Figure 1 and Table 1), which is necessary for the generation of specific cell types and tissues. For example, disruption of the nuclear lncRNA tsRMST in human ESCs caused impaired pluripotency, the upregulation of WNT5A, the epithelial-mesenchymal transition, and lineage-specific gene upregulation, such as GATA4, GATA6, and PAX6. tsRMST can promote pluripotency maintenance by recruiting NANOG and the PRC2 complex factor SUZ12 to suppress lineage-specific gene expression.21 In addition, WNT5A and WNT5B are the functional downstream gene targets suppressed by tsRMST-recruited SUZ12. This abnormal activation of noncanonical WNT signaling caused by tsRMST eventually contributes to ESC pluripotency exit.22 LncRNAs also play regulatory roles in human PSC differentiation into specific germ layers. A study of a genome-scale shRNA library targeting lincRNAs in mESCs led to the identification of a conserved lncRNA, TUNA, which is specifically expressed in the central nervous system of zebrafish, mice, and humans. TUNA not only maintains the pluripotency of ESCs, but also contributes to neural lineage commitment by recruiting PTBP1/hnRNP-K/NCL to the Sox2 promoter. The genetic manipulation of TUNA affected the expression of genes involved in cell differentiation, proliferation, cell death, and neurogenesis in the ESCs studied. Further study showed that TUNA depletion blocked neural differentiation, disturbed neural fate commitment in zebrafish and a mouse model and disrupted neural differentiation in human ESCs.23 In the mesoderm lineage, yylncT, transcribed from the BRACHYURY (T) gene locus and positively correlated with T during cardiac differentiation in human ESCs, regulates ESC differentiation and promotes mesodermal commitment by binding DNMT3B and promoting DNMT3B activity at the T/yylncT locus.24 In addition, the endogenous retrovirus-derived lncRNA BANCR is exclusively expressed in fetal cardiomyocytes and promotes the cardiac differentiation and maturation of human and nonhuman primate PSCs.25 The human-specific lncRNA HBL1 was identified through a transcriptome analysis of ESCs undergoing cardiomyocyte differentiation. The overexpression of HBL1 inhibits and loss-of-function of HBL1 promotes cardiomyocyte differentiation from iPSCs. Mechanistically, SOX2 binds to the HBL1 promoter and activates its transcription. HBL1 regulates cardiomyocyte development by interacting with miR-1 and acting as a miR-1 repressor.26 In 2013, Sigova and colleagues noticed that many lncRNAs were transcribed divergently with adjacent protein-coding genes during the differentiation of both human and mouse ESCs in endoderm.42 This kind of coexpression and coregulation of coding gene-lncRNA pairs is beneficial for lineage specification. In 2015, Jiang and colleagues first demonstrated that the lncRNA DEANR1 was functionally required for human definitive endoderm differentiation. DEANR1 activated the transcription of its nearby gene FOXA2 by facilitating the binding of SMAD2/3 to the FOXA2 promoter.27 Shortly thereafter, DIGIT was reported to regulate human ESCs differentiation to definitive endoderm by positively regulating neighboring GSC transcription.28 Recently, a new mechanism of DIGIT in endoderm differentiation was discovered by the same group. Nuclear-localized DIGIT interacts with BRD3 and promotes BRD3 recruitment at genomic regions with H3K18ac modification, which mainly enhances endoderm transcription factors expression.29 Similar to DEANR1, GATA6-AS1 was recently found to positively regulate GATA6 by recruiting SMAD2/3 and plays an active role in human endoderm differentiation.30 In addition, Chen and colleagues surprisingly found that LINC00458 is required for early endodermal lineage differentiation from human ESCs when they investigated the relationships between matrix stiffness and differentiation. LINC00458 is a stiffness-dependent lncRNA that mediates endodermal lineage specification upon soft substrate induction.31 These examples show that lncRNAs are important regulators in the early lineage specification of human PSCs. 1.3 Mechanisms by which lncRNAs regulate human PSC pluripotency and differentiation There is increasing evidence showing that lncRNAs are implicated in maintaining human PSC pluripotency and directing differentiation through epigenetic, transcriptional, or posttranscriptional regulation of gene expression, which points to flexible and diverse lncRNA functional modes. Considering different interacting partners (ie, chromatin modifiers, transcription factors, other RNA-binding proteins and miRNAs), we summarize the main functional mechanisms of lncRNAs into four categories (Figure 2) and discuss the different functional modes of lncRNAs in human PSCs, illustrating the mechanisms with specific cases. FIGURE 2Open in figure viewer The function mechanisms of lncRNA in human PSCs. LncRNA can interact with different partners to exert function: A, recruiting histone modifiers to regulate local or global chromatin environment; B, facilitating transcription factor binding to specific genomic regions; C, interacting with RNA-binding protein to directly regulate protein function; D, functioning as miRNA sponge to protect miRNA targets 1.3.1 LncRNAs recruit chromatin modifiers and mediate DNA looping LncRNAs can recruit chromatin modifiers to affect chromatin accessibility and transcriptional activity at specific loci in the nucleus. LncRNAs adjacent to key transcription factors in the genome can act in cis to regulate local histone modifications and DNA looping. LncRNA Oct4P4 recruits histone methyltransferases SUV39H1 and HP1a to the Oct4 gene promoter, repressing Oct4 expression and diminishing mouse ESC self-renewal.32 LncRNA RP-11380D23.2 regulates its nearby gene PITX2 in a manner dependent on chromatin-associated protein PARP1 to modulate distal-proximal patterning during lung cell differentiation from human pluripotent stem cells.33 In addition, some lncRNAs may function to regulate target gene transcription outside their local transcriptional niches. The lncRNA tsRMST interacts with the PRC2 component SUZ12 to inhibit WNT5A and WNT5B expression and plays a positive role in promoting human ESC pluripotency maintenance.22 yylncT recruits the de novo DNA methyltransferase DNMT3B to the T/yylncT locus to ensure the activation of T transcription, which is important for mesoderm commitment.24 LncPRESS1 binds to the histone deacetylase SIRT6 and sequesters SIRT6 from the promoters of pluripotent genes, which can maintain high levels of histone H3K56 and H3K9 acetylation at promoters of pluripotency genes and promote pluripotent gene expression.7 Taken together, previous studies show that lncRNAs can regulate the transcription of key pluripotent and developmental genes by recruiting chromatin modifiers and mediating chromatin interactions. 1.3.2 LncRNAs interact with transcription factors Transcription factors are crucial determinators of cell identity. LncRNAs can interact with transcription factors and mediate their binding to the regulatory regions of target genes to regulate gene expression. Ng and colleagues identified three human ESC-specific lncRNAs that physically interact with the transcription factor SOX2 and histone modifier PRC2 to regulate genes important for pluripotency and neurogenesis.3 In endoderm lineage differentiation, DEA